MIF

MIF

MIF 분자 정보

Molecule Name
Macrophage migration inhibitory factor
분자 별명
MIF,GLIF,MMIF,GIF
Drug Development Progress
임상 약물 수3
시판 약물 수1
최고 연구 개발 단계Approved
표적 별명
EC:5.3.2.1,GIF,EC 5.3.3.12,EC 5.3.2.1,Macrophage Migration-Inhibitory Factors,Epididymis Secretory Sperm Binding Protein,EC:5.3.3.12,Phenylpyruvate Tautomerase,L-Dopachrome Tautomerase,MMIF,Glycosylation-inhibiting factor,L-dopachrome isomerase,MIF,Macrophage Migration Inhibitory Factor,Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor),GLIF
분자 배경
Macrophage migration inhibitory factor(MIF) is also known as Glycosylation-inhibiting factor(GIF), L-dopachrome isomerase, L-dopachrome tautomerase, Phenylpyruvate tautomerase. Interacts with CXCR2 extracellular domain, CD74 extracellular domain, COPS5 and BNIPL. The expression of MIF at sites of inflammation suggests a role as mediator in regulating the function of macrophages in host defense. Counteracts the anti-inflammatory activity of glucocorticoids. Has phenylpyruvate tautomerase and dopachrome tautomerase activity (in vitro), but the physiological substrate is not known. It is not clear whether the tautomerase activity has any physiological relevance, and whether it is important for cytokine activity.

MIF 제품 목록

Species
  • Human(1)
Tag
  • His Tag & Avi Tag(1)
Host
  • HEK293(1)
Conjugate
  • Biotin-labeled(1)
Grade
  • RUO(1)
Low Endotoxin
  • No(1)
분자Cat. No.Product Name종Host구조순도Activity규격 및 가격
MIF
Avitag
MIF-H82E7
Biotinylated Human MIF Protein, His,Avitag™
Human
HEK293
SDS-PAGE

$360.00

25ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
IPG-1094IPG-1094; IPG-001Phase 2 ClinicalNanjing Immunophage Biotech Co Ltd
Brain metastases; Brain Neoplasms; Hematologic Neoplasms; Lupus Nephritis; Multiple Myeloma; Multiple Sclerosis; Psoriasis; Solid tumours
상세
TRP2-electroporated autologous dendritic cell therapy (Memorial Sloan-Kettering)Phase 1 ClinicalMemorial Sloan Kettering Cancer Center
Melanoma
상세
STP-1STP-1; STP1Phase 1 ClinicalStalicla Sa
Autism Spectrum Disorder
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
IbudilastKC-404; AV-411; MN-166ApprovedKyorin Pharmaceutical Co LtdKetas, Pinatos, EyevinalJapanAsthma; Multiple Sclerosis; NeuralgiaKyorin Pharmaceutical Co Ltd
Alcoholism; Amyotrophic Lateral Sclerosis; Asthma; Diabetic Neuropathies; Headache Disorders, Secondary; HIV Infections; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Neuralgia; Opioid-Related Disorders; Pneumonia, Viral; Substance-Related Disorders
상세
Customer Reviews
  • S***n2023-04-28
    This product was used for characterization of a novel therapeutic testing kinetics and affinity on SPR with a Cytiva BiotinCAPture kit. It worked phenomenally with both the novel approach and a positive control. Additionally, it was used with a Streptavidin coated ELISA plate (also from Acro), results were phenomenal with that approach as well. Overall, this product has been well received by our team and we have already ordered more to continue testing.